Company has 24 million cash and current mcap is 19 million, with sales revenues near 50 million pounds current price is dirt cheap so iv add 17k it's not showing
Phase 1 and 2 for flu-v is successful and they already have majors intersted it just the regulatory pathways needs to be clarified, trevor done a interview last year , I think it was on the telegraph